Tofacitinib medium (3r, 4R) -1-Benzyl-3- (methylamino) -4, methylpiperidine dihydrochloride; Cis I-Benzyl-IV-METHYL-III-methylamino Piperidine Dihydrochloride cas No. 1062580-52-2

Nostra Tofacitinib medium quoque quae cis-I-benzyl, IV-methyl-III-methylaminopiperidine dihydrochloride et habet casus numerus 1062580-52-2. Et medium est a key ingrediens in productione Tofacitinib, a medicamento solebat tractare RHEUMATOID arthritis, PSoriatic arthritis et ulcerative Colitis. Ut key intermedia in synthesim of Tofacitinib, nostrum products sunt vitalis ad pharmaceutical investigatores et manufacturers.

Hoc medium compositis diligenter synthesized ut summum puritatis et constantia. Cum nostris rei publicae-of-in-arte vestibulum processus et restrictius qualitas potestate mensuras, vos can fiduciam, ut nostra Tofacitinib intermedia occursum summa industria signa pro puritate et stabilitatem.

Tofacitinib medium (3r, 4R) -1-Benzyl-3- (mmethylamino) -4-mmethylpperidine Dihclide habet amplis applications, faciens illud valuable dignissim in pharmaceutical et eget. Utrum vos es faciendi academic research vel developing pharmaceuticals, nostra intermedii componit providere certa et sumptus-effective solutions ad propria necessitates.